Rapid Diagnosis Of Multidrug-Resistant Tuberculosis Impacts Expenditures Prior To Appropriate Treatment: A Performance And Diagnostic Cost Analysis

References

• World Health Organization (WHO). Global tuberculosis report 2018. Geneva: WHO; 2018 WHO/HTM/TB/2018.23.
   Google Scholar
• Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in China, 1990-2010; a longitudinal analysis of national survey data. Lancet. 2014;383(9934):2057–2064. doi:10.1016/S0140-6736(13)62639-224650955
   PubMed Web of Science ®Google Scholar
• Bastos ML, Lan Z, Menzies D. An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis. Eur Respir J. 2017;49:3. doi:10.1183/13993003.00803-2016
   Web of Science ®Google Scholar
• Xu C, Pang Y, Li R, et al. Clinical outcome of multidrug-resistant tuberculosis patients receiving standardized second-line treatment regimen in China. J Infect. 2018;76(4):348–353. doi:10.1016/j.jinf.2017.12.01729374587
   PubMed Web of Science ®Google Scholar
• Dheda K, Gumbo T, Maartens G, et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med. 2017;5:291–360. doi:10.1016/S2213-2600(17)30079-6
   Web of Science ®Google Scholar
• Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366(23):2161–2170. doi:10.1056/NEJMoa110878922670902
   PubMed Web of Science ®Google Scholar
• Tan Y, Li Q, Wang Q, et al. Evaluation of the MTBDRplus 2.0 assay for the detection of multidrug resistance among persons with presumptive pulmonary TB in China. Sci Rep. 2017;7(1):3364. doi:10.1038/s41598-017-03473-728611407
   PubMed Web of Science ®Google Scholar
• Pang Y, Du J, Qin ZZ, et al. An overview on tuberculosis-specific hospitals in China in 2009: results of a national survey. Eur Respir J. 2016;47(5):1584–1587. doi:10.1183/13993003.01854-201526917612
   PubMed Web of Science ®Google Scholar
• Kim SJ. Drug-susceptibility testing in tuberculosis: methods and reliability of results. Eur Respir J. 2005;25(3):564–569. doi:10.1183/09031936.05.0011130415738303
   PubMed Web of Science ®Google Scholar
• Dominguez J, Boettger EC, Cirillo D, et al. Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement. Int J Tuberc Lung Dis. 2016;20(1):24–42. doi:10.5588/ijtld.15.0221
   PubMed Web of Science ®Google Scholar
• Pang Y, Xia H, Zhang Z, et al. Multicenter evaluation of genechip for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2013;51(6):1707–1713. doi:10.1128/JCM.03436-1223515537
   PubMed Web of Science ®Google Scholar
• Pang Y, Dong H, Tan Y, et al. Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China. Sci Rep. 2016;6:25330. doi:10.1038/srep2533027149911
   PubMed Web of Science ®Google Scholar
• National Health and Family Planning Commission of China. Diagnosis for pulmonary tuberculosis; 2008 (WS 288—2008).
   Google Scholar
• Xia H, Song YY, Zhao B, et al. Multicentre evaluation of Ziehl-Neelsen and light-emitting diode fluorescence microscopy in China. Int J Tuberc Lung Dis. 2013;17(1):107–112. doi:10.5588/ijtld.12.018423232010
   PubMed Web of Science ®Google Scholar
• Pang Y, Zhou Y, Zhao B, et al. Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS One. 2012;7(3):e32976. doi:10.1371/journal.pone.003297622412962
   PubMed Web of Science ®Google Scholar
• Storla DG, Yimer S, Bjune GA. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health. 2008;8:15. doi:10.1186/1471-2458-8-1518194573
   PubMed Web of Science ®Google Scholar
• Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J. 2008;32(5):1165–1174. doi:10.1183/09031936.0006180818614561
   PubMed Web of Science ®Google Scholar
• Cavusoglu C, Turhan A, Akinci P, Soyler I. Evaluation of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates. J Clin Microbiol. 2006;44(7):2338–2342. doi:10.1128/JCM.00425-0616825346
   PubMed Web of Science ®Google Scholar
• Lyu J, Kim MN, Song JW, et al. GenoType(R) MTBDRplus assay detection of drug-resistant tuberculosis in routine practice in Korea. Int J Tuberc Lung Dis. 2013;17(1):120–124. doi:10.5588/ijtld.12.019723232012
   PubMed Web of Science ®Google Scholar
• Li Q, Dong HY, Pang Y, et al. Multicenter evaluation of the molecular line probe assay for multidrug resistant mycobacterium tuberculosis detection in China. Biomed Environ Sci. 2015;28(6):464–467. doi:10.3967/bes2015.06626177909
   PubMed Web of Science ®Google Scholar
• Zheng C, Li S, Luo Z, et al. Mixed infections and rifampin heteroresistance among mycobacterium tuberculosis clinical isolates. J Clin Microbiol. 2015;53(7):2138–2147. doi:10.1128/JCM.03507-1425903578
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lu J, Wang Y, Pang Y, Zhao Y. Automated liquid culture system misses isoniazid heteroresistance in mycobacterium tuberculosis isolates with mutations in the promoter region of the inhA gene. Eur J Clin Microbiol Infect Dis. 2015;34(3):555–560.25344830
   PubMed Web of Science ®Google Scholar
• Pfyffer GE, Welscher HM, Kissling P, et al. Comparison of the Mycobacteria Growth Indicator Tube (MGIT) with radiometric and solid culture for recovery of acid-fast bacilli. J Clin Microbiol. 1997;35(2):364–368.9003597
   PubMed Web of Science ®Google Scholar
• Idigoras P, Beristain X, Iturzaeta A, Vicente D, Perez-Trallero E. Comparison of the automated nonradiometric bactec MGIT 960 system with Lowenstein-Jensen, Coletsos, and Middlebrook 7H11 solid media for recovery of mycobacteria. Eur J Clin Microbiol Infect Dis. 2000;19(5):350–354. doi:10.1007/s10096005049210898135
   PubMed Web of Science ®Google Scholar
• Opota O, Senn L, Prod’hom G, et al. Added value of molecular assay Xpert MTB/RIF compared to sputum smear microscopy to assess the risk of tuberculosis transmission in a low-prevalence country. Clin Microbiol Infect. 2016;22(7):613–619. doi:10.1016/j.cmi.2016.04.01027139592
   PubMed Web of Science ®Google Scholar
• Lawn SD, Mwaba P, Bates M, et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis. 2013;13(4):349–361. doi:10.1016/S1473-3099(13)70008-223531388
   PubMed Web of Science ®Google Scholar
• Seifert M, Ajbani K, Georghiou SB, et al. A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2016;20(5):631–637. doi:10.5588/ijtld.15.078827084817
   PubMed Web of Science ®Google Scholar